Home
Drugs
Targets
Pathways
Ontologies
Cyp450s
Adv.search
Help/FAQ

Drug Details

add
Name:Bimatoprost
PubChem ID:5311027
Pathway:Show KEGG pathways
InChI:InChI=1/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1/f/h26H
SMILES:CCNC(CCCC(/[H])=C(/[H])C[C@H]1[C@H](C(=C(/[H])[C@@H](CCc2ccccc2)O)\[H])[C@H](C[C@@H]1O)O)=O

Properties:
Formula:C25H37NO4Atoms:39
Molecular Weight:415.566Rotatable Bonds:13
H-bond Acceptors:5H-bond Donors:0
logP:3.5378
Targets:
Synonyms:
(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-penteny
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
155206-00-1
15M
267244-98-4
5-Heptenamide, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (5Z)-
5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-
5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-1(alpha(Z),2beta(1E,3S*)3alpha,5alpha))-
5-Heptenamide,7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ehtyl-,(5Z)
AGN 192024
AGN-192024
Bimataprost [USAN:INN:BAN]
Bimatoprost
Bimatoprost (USAN/INN)
CHEBI:51230
D02724
DB00905
Latisse
LS-181817
Lumigan
Lumigan (TN)
NCGC00181745-01
ZINC04474405
ATC-Codes:
Side-Effects:
Side-EffectFrequency
insomnia0
sinusitis0
visual field defect0
rhinitis0
pruritus0
pharyngitis0
palpitations0
pain0
nervousness0
keratitis0
iritis0
infection0
erythema0
upper respiratory tract infection0
blurred vision0
dry eyes0
watery eyes0
eye pain0
liver function tests abnormal0
cataract0
peripheral edema0
photophobia0
burning sensation0
dry mouth0
uveitis0
hypertension0
hypercholesterolemia0
cough0
conjunctivitis0
chest pain0
chalazion0
bronchitis0
blistering0
blepharospasm0
blepharitis0
asthenopia0
asthenia0
arthritis0
cystitis0
diplopia0
hordeolum0
hirsutism0
headache0
glaucoma0
vitreous floaters0
rash0
edema0
dyspnea0
dyspepsia0
somnolence0
dizziness0
anxiety0